Results 81 to 90 of about 22,286 (230)

A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum. [PDF]

, 2017
Erythema nodosum leprosum (ENL) is a painful inflammatory complication of leprosy occurring in 50% of lepromatous leprosy patients and 5-10% of borderline lepromatous patients.
Abalos, Abdallah, Abdallah, Adhe, Anders, Anderson, Anderson, Anderson, Andreoli, Anthony, Anthony, Anthony, Antunes, Attia, Attia, Auttachoat, Baatrup, Bach, Bach, Barnes, Belgaumkar, Berrington, Berrington, Beuria, Beuria, Beyrau, Bhattacharya, Bhoopat, Bjorvatn, Blavy, Boer, Bottasso, Brito Mde, Britton, Brusko, Buckle, Bullock, Chaitanya, Chakrabarty, Chakrabarty, Chandler, Chowdhry, Das, de Azevedo, de la Barrera, de Messias, de Sales Marques, Dias, Dubey, Dupnik, Faber, Fatima, Fehervari, Filley, Foss, Freire, Furukawa, Gelber, Geniteau, Goihman-Yahr, Goulart, Grevink, Hamerlinck, Harikrishan, Haslett, Haslett, Hauptmann, Hernandez Mde, Herra, Hogg, Hoiby, Humphres, Hussain, Hussain, Iyer, Iyer, Izumi, Jacobson, Jadhav, Jayapal, Job, Kifayet, Kifayet, Kim, Kim, Kruger, Laal, Lange, Langereis, Lee, Leliefeld, Levis, Levis, Lewis, Libert, Lim, Lockwood, Mabalay, Madan, Mahaisavariya, Mahaisavariya, Mandal, Martiniuk, Massone, Memon, Mendonca, Miller, Miyao, Modlin, Modlin, Modlin, Modlin, Mohanty, Mohanty, Moraes, Moraes, Moran, Motta, Moubasher, Moubasher, Mshana, Mshana, Mshana, Murphy, Narayanan, Nath, Nath, Nigam, Nishimura, Ohi, Oliveira, Parente, Parida, Partida-Sanchez, Penttinen, Pepler, Pocaterra, Rada, Rada, Ramanathan, Ramanathan, Ramanathan, Ramien, Rao, Rao, Rao, Rasheed, Rea, Rea, Rea, Rea, Reichlin, Ridley, Ridley, Rodrigues, Rojas, Rojas, Rojas-Espinosa, Saha, Saha, Saini, Saini, Saini, Saini, Sakane, Sallam, Sampaio, Sampaio, Sampaio, Sampaio, Santegoets, Santos, Santos, Santos, Sarita, Sarno, Sasiain, Sasiain, Schifferli, Schifferli, Schmitz, Schon, Schuring, Schwerer, Scollard, Scollard, Scotland, Sehgal, Sehgal, Sehgal, Sehgal, Sehgal, Sehgal, Shamseer, Shen, Sher, Silva, Singh, Singh, Song, Sousa, Stefani, Stefani, Sullivan, Sunderkotter, Tadesse, Tan Trao, Teixeira, Teles, Trao, Tung, Turk, Tyagi, Tyagi, Valentijn, Vieira, Villahermosa, Voorend, Wager, Walker, Walker, Wallach, Wallach, Waters, Wemambu, Wiggins, Wolkenstein, Yanase, Ye   +228 more
core   +2 more sources

Management of Treatment Resistant EGFR Inhibitor‐Induced Papulopustular Exanthema With Isotretinoin and Dapsone

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Background/Objectives Epidermal growth factor receptor inhibitors (EGFRi) commonly cause papulopustular exanthemas that may compromise the success of cancer therapy. While tetracyclines are first‐line treatment, data on alternative systemic agents for refractory cases remain limited.
Ishana Dixit, Raquel Ruiz Araujo, Pablo Fernandez‐Peñas   +2 more
wiley   +1 more source

Dapsone-induced agranulocytosis leading to perianal abscess and death: a case report

Journal of Medical Case Reports, 2011
Introduction Dapsone (diaminodiphenylsulfone) is used for the treatment of intractable skin diseases such as pemphigus and leprosy. The side effects of Dapsone are anemia, leukopenia, and liver dysfunction.
Kitamura Nobuya, Setoguchi Daisuke, Kobe Yoshiro   +2 more
doaj   +1 more source

Unmet Needs in Treatment Escalation for Chronic Spontaneous Urticaria: Findings From the CURE Registry

Allergy, EarlyView.
Appropriate treatment escalation improves CSU disease control. However, only about a quarter of patients achieve a complete response, the main goal of CSU treatment. Approximately one‐third of patients clinically eligible for escalation (UCT < 12) do not receive guideline‐recommended treatment escalation and remain symptomatic on their current ...
Pavel Kolkhir, Pascale Salameh, Magdalena Zajac, Alicja Kasperska‐Zajac, Ana Giménez‐Arnau, Maria Puertolas, Hanna Bonnekoh, Carolina Vera Ayala, Michael Makris, Eleni Chatzidimitriou, Stamatios Gregoriou, Kanokvalai Kulthanan, Andrea Bauer, Mojca Bizjak‐Suran, Daria Fomina, Alexis Bocquet, Joachim Dissemond, Mohamed Abuzakouk, Tara Raftery, Nadine Chapman‐Rothe, Emek Kocatürk, Clive Grattan, Riccardo Asero, Jonny G. Peter, Simon Francis Thomsen, Karsten Weller   +25 more
wiley   +1 more source

Aortic dissection type A, common carotid artery occlusion, and stroke after dapsone for 20 years

Journal of Family Medicine and Primary Care
Long-term use of dapsone, a sulfone with anti-inflammatory and immunosuppressive properties, has not been previously reported in association with aortic dissection type A.
Josef Finsterer, Sounira Mehri
doaj   +1 more source

Accidental dapsone ingestion leading to methemoglobinemia in a child: A case report

Journal of Pediatric Critical Care, 2019
Dapsone is a sulfone antibacterial drug used in the treatment of Leprosy and common skin conditions such as acne. Known to cause hypersensitivity syndromes apart from adverse effects such as tachycardia, tachypnea, vomiting, hemolytic anemias and ...
Venkat Sandeep Reddy, Ajay Walimbe, Bhakti Sarangi, Sanjay Lalwani   +3 more
doaj   +1 more source

Linear IgA dermatosis induced by pregnancy [PDF]

, 2008
A dermatose por IgA linear é doença bolhosa auto-imune subepidérmica rara, caracterizada pelo depósito linear de IgA na zona da membrana basal da epiderme. Nos relatos de gestação em pacientes com essa dermatose, nota-se sempre melhora do quadro clínico.
AOKI, Valéria, KANAGUSUKO, Telma, SANCHEZ, Ana Paula Galli, TEBCHERANI, Antonio José   +3 more
core   +4 more sources

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria

Allergy, EarlyView.
ABSTRACT This update and revision of the international guideline for urticaria was developed in accordance with the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is an initiative of the Global Allergy and Asthma Excellence Network (GA2LEN) and its Urticaria and ...
T. Zuberbier, Z. Abdul Hameed Ansari, A. H. Abdul Latiff, M. M. Abuzakouk, M. S. Agcaoili‐De Jesus, R. C. Agondi, M. Al‐Ahmad, A. A. Alangari, H. Alhameli, C. D. Alonso Bello, S. Alshareef, S. Al‐Tamemi, S. Altrichter, H. Al Wahshi, S. Aquilina, M. Araújo, R. Arnaout, R. Asero, B. Ballmer‐Weber, C. Bangert, A. Bauer, M. Ben‐Shoshan, J. A. Bernstein, C. Bindslev‐Jensen, M. Bizjak, I. Boccon‐Gibod, H. Bonnekoh, L. Bouillet, K. Brockow, Z. Brzoza, M. Bulatović Ćalasan, A. Bulkhi, T. Buttgereit, A. Bygum, T. Caballero, O. Calderon, R. Campos, M. Cancian, E. Carne, M. A. Castor, I. Cerecedo, T. Çetinarslan, I. Cherrez‐Ojeda, N. Chkhikvadze, H. J. Chong‐Neto, K. Choo, G. Christoff, C.‐Y. Chu, K. Ciupka, N. Conlon, C. Costa, T. Craig, P. Criado, I. Danilycheva, R. Darlenski, E. De Arruda Chaves, L. de Montjoye, M. S. Doutre, A. Du‐Thanh, D. Ebo, S. Elkhalifa, S. Elmariah, T. El‐Shanawany, L. F. Ensina, R. Ertaş, R. Fachini Jardim Criado, M. Ferrer, S. Ferrucci, J. S. Fok, D. Fomina, L. Fonacier, G. Fouda, I. Francescantonio, A. Fukunaga, C. A. Galvan Calle, E. Garcia, K. Gáspár, A. Gelincik, S. Geng, K. Godse, M. Gonçalo, M. Gotua, C. Grattan, M. Grosber, G. Guidos Fogelbach, M. Guilarte, R. Guillod, E. Hamelmann, J. Hawkes, K. Hayama, R. Heuer, M. Hide, W. Hoetzenecker, N. Inomata, H.‐R. Kang, A. Kaplan, A. Kapp, M. Karam, A. Kasperska‐Zajac, C. H. Katelaris, A. Kessel, M. Khoshkhui, B. Kim, T. Kinaciyan, E. Kocatürk, M. Kolacinska‐Flont, P. Kolkhir, G. N. Konstantinou, M. Kosnik, D. Krasowska, K. Kulthanan, M. S. Kumaran, I. Kuprys‐Lipinska, M. Labrador, J. I. Larco, D. Larenas‐Linnemann, E. Latysheva, E. Lazaridou, P. H. Li, H. Lima, U. Lippert, M. Magerl, M. Makris, J. Alves Marcelino, A. V. Marzano, I. Medina, R. Meshkova, D. Micallef, R. Mohammed Ali, C. G. Mortz, M. Munoz, H. N. G. Oude Elberink, A. Nakonechna, I. Nasr, A. Nast, E. Netchiporouk, E. Nettis, S. Nieto, I. Ogueta Canales, T.‐L. Okas, R. L. Orfali, E. Özkaya, C. Parisi, A. Pennitz, R. Pawankar, M. P. Pereira, J. Peter, E. Petkova, P. D. Pigatto, I. Podder, T. Popov, G. Porebski, P. Pyatilova, G. D. Ramon, H. A. Ratti Sisa, M. Recto, K. Ress, K. Ridge, M. Riedl, C. Ritchie, N. Rosario Filho, I. Rosmaninho, M. Rudenko, M. Rukhadze, K. Rutkowski, V. Sabato, U. M. Sahiner, S. Saini, F. Saleh Al Sabbagh, A. Salman, F. Salvo, J. Sanchez, A. Santucci, S. Schliemann, P. Schmid‐Grendelmeier, B. E. Sekerel, F. Serpa, F. Sheikh, J. Sheikh, H. Shendi, F. Siebenhaar, M. Sonomjamts, A. Soria, B. Sousa Pinto, M. Staevska, P. Staubach, M. Stephan, K. Stevanovic, L. Stingeni, M. Stobiecki, Ö. Su Küçük, G. Sussman, A. Szegedi, S. Takahagi, A. Tanaka, N. Teovska Mitrevska, S. F. Thomsen, E. Toubi, F. Tsatsou, M. Turk, Z. Vadasz, A. Valerieva, S. Valle, M. v. Doorn, B. Veleiro Perez, C. E. Vera Ayala, C. Vestergaard, R. J. Vieira, C. W. Maruta, B. Wedi, R. N. Werner, E. W. Y. Yap, P. Xepapadaki, Y. Xiang, Y.‐M. Ye, P. Yong, G. Yosipovitch, A. Z. J. Zalewska‐Janowska, C. Zeyen, Z. Zhao, M. Metz, A. M. Giménez‐Arnau   +221 more
wiley   +1 more source

Pharmacological considerations in the design of anti-malarial drug combination therapies - is matching half-lives enough? [PDF]

, 2014
Anti-malarial drugs are now mainly deployed as combination therapy (CT), primarily as a mechanism to prevent or slow the spread of resistance. This strategy is justified by mathematical arguments that generally assume that drug 'resistance' is a binary ...
Hodel, Eva Maria
core   +1 more source

Wells syndrome: clinical findings and management in a large cohort of 48 patients

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives: Wells syndrome (WS) is a rare inflammatory skin disorder typically characterized by erythematous, edematous, and pruritic plaques. Despite its distinct histopathological features, WS remains an underdiagnosed disease due to its variable clinical presentations and overlap with other dermatological conditions.
Marco Adriano Chessa, Silvia Robuffo, Tullio Brunetti, Luca Rapparini, Bianca Maria Piraccini, Cosimo Misciali, Beatrice Raone, Iria Neri, Federica Filippi   +8 more
wiley   +1 more source